Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lavien Group is an investment management firm founded in 2012 and based in New York. The company invests in a concentrated portfolio of companies with strong records of long-term value creation, innovation, and significant insider ownership. It applies private equity-style analysis to public stock selection, aiming for private-equity-like returns with greater liquidity and shorter timeframes than traditional PE funds[1]. There is no evidence that it develops drugs or healthcare products itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lavien Group.